Retatrutide, a novel dual stimulator of the GLP-1 target and glucose-dependent secreted polypeptide (GIP) target, is showing promising outcomes in early human studies. Recent research indicates that https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/